This provider's $9.5M in total Medicare payments ranks in the 90th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 178% from 2022 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 178% in 2023
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2022 | $40.60 | $33.30 | 1.22x | $7.30 | $2.5M | 75.9K | 26 |
| 2023 | $35.83 | $30.53 | 1.17x | $5.30 | $7.0M | 229.7K | 41 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | 130.8K | $4.5M | $34.39 | 1.19x |
| 87150 | Identification of organisms by genetic analysis, amplified probe technique | 53.8K | $1.8M | $34.39 | 1.16x |
| 87481 | Detection test for candida species (yeast), amplified probe technique | 41.5K | $1.4M | $34.39 | 1.19x |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 9.4K | $323.4K | $34.39 | 1.16x |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 9.3K | $318.9K | $34.39 | 1.16x |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 7.6K | $260.9K | $34.39 | 1.16x |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 7.5K | $256.9K | $34.39 | 1.16x |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 2.0K | $68.8K | $34.39 | 1.16x |
| 87486 | Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique | 1.9K | $66.1K | $34.39 | 1.16x |
| 87581 | Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique | 1.9K | $66.1K | $34.39 | 1.16x |
| 87541 | Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique | 1.9K | $65.8K | $34.39 | 1.16x |
| 82306 | Vitamin d-3 level | 1.1K | $32.6K | $28.99 | 1.11x |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | 1.6K | $26.7K | $16.46 | 1.46x |
| 86003 | Measurement of antibody (ige) to allergic substance, crude allergen extract, each | 4.9K | $25.0K | $5.12 | 1.08x |
| 84480 | Thyroid hormone, t3 measurement, total | 1.6K | $22.4K | $13.90 | 1.22x |
| 82746 | Folic acid level, serum | 1.5K | $21.9K | $14.41 | 1.23x |
| 82607 | Cyanocobalamin (vitamin b-12) level | 1.3K | $19.5K | $14.78 | 1.84x |
| 84403 | Testosterone (hormone) level, total | 708 | $17.9K | $25.29 | 1.19x |
| 84439 | Thyroxine (thyroid chemical), free | 1.6K | $14.0K | $8.84 | 1.36x |
| 82150 | Amylase (enzyme) level | 1.6K | $10.1K | $6.35 | 2.10x |
This provider submits charges 1.19 times higher than what Medicare actually pays.
A markup ratio of 1.19x means for every $100 Medicare pays, this provider initially charges $119. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in CA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Genomic Health, Inc. | Redwood City, CA | $887.6M | ✓ Clear |
| Unilab Corporation | West Hills, CA | $868.8M | ⚠️ Flagged |
| Caredx Inc. | Brisbane, CA | $751.0M | ✓ Clear |
| Laboratory Corporation Of America | San Diego, CA | $592.4M | ⚠️ Flagged |
| Millennium Health, Llc | San Diego, CA | $587.9M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data